Hopen Life Science Ventures is a venture capital firm, investing in the life science and healthcare sectors.
Business Model:
Revenue: $4M
Employees: 2-10
Address: 171 Monroe Ave NW
City: Grand Rapids
State: MI
Zip: 49503
Country: US
Hopen Therapeutics is a private investment and management firm focused on helping early- to mid-stage life science developments achieve commercial success. We&s;re interested in promising pharmaceutical and healthcare concepts, and offer idea owners three key advantages: ample funding, development and managerial expertise, and a broad network of industry relationships.
Contact Phone:
+16163252110
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
1/2010 | Nymirum | Grant | 2.8M |
1/2008 | Metabolic Solutions Development | Series B | - |
10/2012 | Tolera Therapeutics | Series B | 0 |
9/2014 | Prevacept Infection Control | Venture Round | 0 |
9/2015 | Delphinus Medical Technologies | Series C | 0 |
7/2011 | Trapelo Health | Series B | 0 |
9/2022 | Delphinus Medical Technologies | Series D | 0 |
4/2014 | Sierra Oncology | Series D | 0 |
4/2017 | Cirius Therapeutics | Series A | 0 |
4/2014 | Bjond | Series A | 3.3M |
10/2010 | Metabolic Solutions Development | Series D | 23.5M |
6/2015 | NeoChord | Series C | 0 |
9/2022 | Delphinus Medical Technologies | Series D | 0 |
4/2017 | Cirius Therapeutics | Series A | 0 |
9/2015 | Delphinus Medical Technologies | Series C | 0 |
6/2015 | NeoChord | Series C | 0 |
9/2014 | Prevacept Infection Control | Venture Round | 0 |
4/2014 | Sierra Oncology | Series D | 0 |
4/2014 | Bjond | Series A | 0 |
10/2012 | Tolera Therapeutics | Series B | 0 |
7/2011 | Trapelo Health | Series B | 0 |
10/2010 | Metabolic Solutions Development | Series D | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|